Zealand Pharma Surges on Promising Weight Loss Drug Trial Resultsby Mark Eisenberg 21.06.2024Zealand Pharma's stock surged 17% post-positive trial results for its weight loss drug, showing promising 8.6% average weight reduction. Analysts ...
Q3 2024 Commodity Forecast: Oil, Copper, and Gas Insightsby Mark Eisenberg 21.06.2024Explore the Q3 2024 commodity forecast. Discover trends in oil, gold, copper, and natural gas prices and their implications for ...
ICC Arbitration’s Rise in Colombia: Project Finance Impactby Mark Eisenberg 21.06.2024"Explore why arbitration is the top choice for resolving disputes in Colombia's 4G and 5G projects, and its growing future ...
Wells Fargo Urges Clients to Cut Exposure to Overvalued Tech Stocksby Mark Eisenberg 21.06.2024Wells Fargo advises reducing tech stock exposure due to overvaluation and narrow market rally dominated by a few giants, suggesting ...
US Chipmaker Onsemi to Invest $2B in Czechiaby Mark Eisenberg 21.06.2024"US chipmaker Onsemi to invest $2B in Czechia, boosting the local economy, enhancing the high-tech sector, and strengthening global semiconductor ...
Bitcoin, Ethereum, Dogecoin in Range: Reversal on Horizon?by John Darbie 21.06.2024Cryptocurrencies remain rangebound; analysts predict an upward reversal for Bitcoin, Ethereum, and Dogecoin. Investors await new trading triggers.
Jazz’s Midphase Tremor Drug Misses Mark, Future Uncertainby Lilu Anderson 20.06.2024Jazz Pharmaceuticals hits a hurdle as its essential tremor drug trial misses primary endpoint. Awaiting Parkinson's trial results for future ...
Esperion Stock Downgraded Amid Merck’s Competitive Pressureby Mark Eisenberg 20.06.2024Esperion's stock downgraded by BofA due to rising competition from Merck's PCSK9 inhibitors. Analysts weigh in on efficacy and market ...
ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cutby Mark Eisenberg 20.06.2024Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...
Iontronic Tech Promises Hope in Slowing Malignant Brain Tumorsby Lilu Anderson 20.06.2024"Iontronic tech shows promise in slowing malignant brain tumor growth by continuously delivering low-dose drugs, bypassing the blood-brain barrier."